Profile
Full Name
Aprea Therapeutics, Inc.Ticker Symbol
APREExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
October 3, 2019Indexes
Not includedWebsite
http://www.aprea.comEmployees
8Key Details
Price
$1.56(-1.27%)
Market cap
$8.48M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$2.35(+40.51% YoY)
PE ratio
-
Next earnings date
May 14, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Aprea Therapeutics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Jan 15, 25 HC Wainwright & Co.
BuyDec 17, 24 HC Wainwright & Co.
BuyNov 18, 24 HC Wainwright & Co.
BuyOct 24, 24 HC Wainwright & Co.
BuyAug 13, 24 Wedbush
OutperformAug 12, 24 HC Wainwright & Co.
BuyJun 24, 24 HC Wainwright & Co.
BuyJun 17, 24 HC Wainwright & Co.
BuyMay 14, 24 HC Wainwright & Co.
BuyMar 27, 24 Wedbush
OutperformInstitutional Ownership
- What is the ticker symbol for Aprea Therapeutics?
- Does Aprea Therapeutics pay dividends?
- What sector is Aprea Therapeutics in?
- What industry is Aprea Therapeutics in?
- What country is Aprea Therapeutics based in?
- When did Aprea Therapeutics go public?
- Is Aprea Therapeutics in the S&P 500?
- Is Aprea Therapeutics in the NASDAQ 100?
- Is Aprea Therapeutics in the Dow Jones?
- When was Aprea Therapeutics's last earnings report?
- When does Aprea Therapeutics report earnings?
- Should I buy Aprea Therapeutics stock now?
What is the ticker symbol for Aprea Therapeutics?
The ticker symbol for Aprea Therapeutics is NASDAQ:APRE
Does Aprea Therapeutics pay dividends?
No, Aprea Therapeutics does not pay dividends
What sector is Aprea Therapeutics in?
Aprea Therapeutics is in the Healthcare sector
What industry is Aprea Therapeutics in?
Aprea Therapeutics is in the Biotechnology industry
What country is Aprea Therapeutics based in?
Aprea Therapeutics is headquartered in United States
When did Aprea Therapeutics go public?
Aprea Therapeutics's initial public offering (IPO) was on October 3, 2019
Is Aprea Therapeutics in the S&P 500?
No, Aprea Therapeutics is not included in the S&P 500 index
Is Aprea Therapeutics in the NASDAQ 100?
No, Aprea Therapeutics is not included in the NASDAQ 100 index
Is Aprea Therapeutics in the Dow Jones?
No, Aprea Therapeutics is not included in the Dow Jones index
When was Aprea Therapeutics's last earnings report?
Aprea Therapeutics's most recent earnings report was on Mar 25, 2025
When does Aprea Therapeutics report earnings?
The next expected earnings date for Aprea Therapeutics is May 14, 2025
Should I buy Aprea Therapeutics stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions